NKCFO LLC’s West Pharmaceutical WST Stock Holding History

NKCFO LLC’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,400	Closed	-$318K	–	127
2020 Q2	$318K	Hold	1,400	–	–	0.21%	32
2020 Q1	$213K	Buy	+1,400	New	+$215K	0.2%	48

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

NKCFO LLC's WST Position: Q3 2020 in Review

NKCFO LLC sold out of West Pharmaceutical (WST) in Q3 2020, closing a stake of 1,400 shares — an estimated $318K sold.

NKCFO LLC first reported a position in WST in Q1 2020 and held it in 2 quarters. The position peaked at $318K in Q2 2020. 574 funds tracked by Wall St. Rank hold WST as of Q3 2020.

NKCFO LLC reported no remaining West Pharmaceutical position as of Q3 2020 after selling out during the quarter.
NKCFO LLC sold 1,400 West Pharmaceutical shares in Q3 2020, an estimated $318K.
NKCFO LLC first reported a position in West Pharmaceutical in Q1 2020 and held it in 2 quarters.
NKCFO LLC's West Pharmaceutical position peaked at $318K in Q2 2020.
574 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2020.

Based on NKCFO LLC's 13F filing for Q3 2020, filed 4 Nov 2020.